Sl. No. Title Patent No Brand /Ingredient
1 Microbial bioconversion of curcuminoids to Calebin-A US 11,299,706 Curcousin
2 Isolates from spent turmeric for the management of rheumatoid arthritis US 11,298,395 Starmeric®
3 Modulation of immune function by Bacillus coagulans US 11,298,381 Immunospore
4 Hypolipidemic effects of Bacillus coagulans US 11,213,553 LactoSpore®
5 Stable probiotic composition for the management of lactose intolerance US 11,202,810 LactoSpore®
6 Fructophilic lactic acid producing bacteria US 11,197,898 Fructospore®
7 Hair care compositions containing extracellular metabolite preparation from Bacillus
coagulans
US 11,123,382 LactoSporin®
8 Beverage compositions containing Bacillus coagulans MTCC 5856 US 11,052,125 LactoSpore®
9 Compositions for weight loss US 11,052,125 Cyperus + Forskolin + Garcinol
10 Composition for the therapeutic management of hypomelanotic skin conditions US 11,045,517 Forskolin + Nigellin®
11 Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans
MTCC 5856
US 10,966,919 LactoSporin®
12 Bioactive molecules from Oroxylum indicum and their therapeutic applications US 10,959,980 Sabroxy®
13 Compositions containing thymohydroquinone and their method of preparation US 10,945,969 Nigellin®
14 Method of inhibiting propionibacterium acnes US 10,898,536 Artocarpus
15 Neuroprotective compositions and their use US 10,894,029 Sabroxy®
16 Compositions for the management of hyperglycemia and related conditions US 10,881,623 Nigellin®
17 Composition for prostaglandin transporter inhibition and related therapeutic applications US 10,864,243 Sabeet® + Nigellin® + Arjuna + SelenoForce®
18 Aphrodisiac composition and management of male sexual dysfunction US 10,864,242 Xxtrastrong
19 Skin care compositions and their applications US 10,864,154 Ethyl ascorbic acid + THC
20 Compositions and methods for reducing flatulence US 10,806,760 LactoSpore®
21 Composition for management of Helicobacter pylori infection US 10,792,295 LactoSpore® + Saberry®
22 Adaptogenic compositions and applications thereof US 10,716,823 Polybos + Saberry®
Polybos + Cococin
23 Stable probiotic composition containing Bacillus coagulans MTCC 5856 and method
of detection thereof
US 10,668,115 LactoSpore®
24 Liver protectant compositions and therapeutic applications US 10,653,643 LivLonga®
25 Beverage compositions containing Bacillus coagulans MTCC 5856 US 10,609,935 LactoSpore®
26 Process for preparing tripeptide containing oleanolic acid and its therapeutic
applications thereof
US 10,588,844 Oletrip
27 Composition containing Oroxylin A and method of extraction thereof US 10,555,982 Oroxylin
28 Telomerase enhancement potential of Ecdysterone US 10,548,902 Ecdysterone
29 Functional nutritional blend for thermo-metabolic performance US 10,477,886 Metabolicgard
30 Process for the preparation of standardized composition of arjunoglucoside from the bark
of Terminalia arjuna
US 10,479,749 Arjunoglucoside
31 Process for the preparation of enantiopure 3-amino tetrahydrofuran and its salts US 10,421,734 3-Amino Tetrahydrofurans
32 Process for synthesis of Oroxylin A US 10,407,401 Sabroxy®
33 Process for enhancing the viable counts of lactic acid bacteria and useful compositions
thereof
US 10,323,227 LactoSpore® + Starmeric
34 Process for enhancing the viable counts of lactic acid bacteria and useful compositions
thereof
US 10,293,008 LactoSpore®
35 Novel PCR primers and methods thereof for the identification of Bacillus
coagulans
MTCC 5856
US 10,260,112 LactoSpore®
36 Functional nutritional blend for thermo-metabolic performance US 10,258,073 Metabolicgard
37 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof US 10,172,903 Cyperus
38 Bacillus coagulans MTCC 5856 for the management of major depressive disorder US 10,166,261 LactoSpore®
39 Process and compositions for achieving mammalian energy balance US 10,085,963 Forskolin
40 Oleanoyl peptide composition and skin hydration US 10,071,043 Olepent®
41 Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl) butadiene US 9,913,809 Zingiber cassumnar
42 Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl) butadiene US 9,833,422 Zingiber cassumnar
43 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof US 9,782,450 Cyperus
44 Calebin A for hepatic steatosis US 9,737,502 Calebin
45 Process for enhancing the viable counts of lactic acid bacteria and useful compositions
thereof
US 9,717,766 LactoSpore® + LactoCran
46 Method of producing partially purified extracellular metabolite products from Bacillus
coagulans
and biological applications thereof
US 9,681,666 LactoSporin® + SabiLize®
47 Method of producing partially purified extracellular metabolite products from Bacillus
coagulans
and biological applications thereof
US 9,681,665 LactoSporin®
48 Method for the treatment of hypercholesterolemia US 9,668,999 Calebin
49 Method of producing partially purified extracellular metabolite products from Bacillus
coagulans
and biological applications thereof
US 9,635,862 LactoSporin®,
LactoSporin® + Sabilize®
50 Method for the treatment of hypercholesterolemia US 9,610,273 Calebin
51 Method of producing partially purified extracellular metabolite products from Bacillus
coagulans
and biological applications thereof
US 9,596,861 LactoSporin®
52 Process for the therapeutic management of Diarrhea predominant irritable bowel syndrome
using Bacillus coagulans
US 9,579,352 LactoSpore®
53 Calebin A for osteoporosis US 9,539,232 Calebin
54 Synergistic selenopeptide formulations for the protection of dermal papilla cells US 9,498,423 Saberry® + Cococin + Se Peptide
55 Process for the manufacture of 3′-hydroxy pterostilbene US 9,458,075 3-hydroxypterostilbene
56 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof US 9,387,193 Cyperus
57 Synthesis of Calebin A and its biologically active analogs US 9,365,486 Calebin
58 Anti-obesity potential of Calebin A US 9,328,330 Calebin
59 Composition and method for the protection of articular cartilage US 9,220,703 Calebin
60 Orally bioavailable stilbenoids-compositions and therapeutic applications thereof US 9,056,074 3-hydroxypterostilbene
61 Orally bioavailable stilbenoids-compositions and therapeutic applications thereof US 9,050,284 3-hydroxypterostilbene
62 Synthesis of 4-aryl 4-acyl piperidine, its salts and analogs using indium metal US 9,029,547 Pharmaceutical Intermediates
63 Orally bioavailable stilbenoids-compositions and therapeutic applications thereof US 9,029,424 3-hydroxypterostilbene
64 Oleanoyl peptide composition and method of treating skin aging US 8,987,212 Olepent®
65 Anti-obesity potential of Calebin A US 8,933,121 Calebin
66 Novel synthesis of 4-aryl 4-acyl piperidine, its salts and analogs using indium metal US 8,853,407 Pharmaceutical intermediates
67 Inotilone derivatives as coherent biological response modifier (cBMR) US 8,394,852 Inotilone derivatives
68 Peptides modified with triterpenoids and small organic molecules: synthesis and use in
cosmeceuticals
US 8,383,594 Olepent®
69 Compositions and its use in treating obesity or inducing weight loss US 8,329,743 Livinol+ Pterostilbene + Anthocyanin
70 Preservative system for cosmetic formulations—compositions and methods thereof US 8,329,095 SabiLize®
71 Protective compositions for dermal papilla cells US 8,247,003 Saberry® + Cococin
72 Dipeptides incorporating selenoamino acids with enhanced bioavailability–synthesis,
pharmaceutical and cosmeceutical applications thereof
US 8,193,156 LSM-Dipeptide Synthetic route
73 Treatment of superficial and cutaneous mycoses with a pure form of
1,7-bis(4-hydroxy-3-methoxyphe nyl)-3,5-heptanedione
US 8,119,696 Tetrapure®
74 Dipeptides incorporating selenoaminoacids with enhanced bioavailability-synthesis US 8,003,614 MSC-Dipeptide Synthetic route
75 Hydro-alkoxyl citronellal compounds – synthetic routes, compositions and uses thereof US 7,842,842 Woody Odorants
76 Composition and methods for the management of hyperproliferative dermatological conditions US 7,582,314 Boswellin®
77 Novel non-cytotoxic synthetic analogues of (1E, 6E )-1,7-Bis (4
hydroxy-3-methoxyphenyl)-1,6-heptadiene-3, 5-dione and therapeutic applications thereof in cystic
fibrosis
US 7,521,580 Curcuminoid analogs
78 Processes for the manufacture of chiral and racemic forms of 3-aminotetrahydrofurans,
their salts and derivatives
US 7,514,573 3-Aminotetrahydrofurans
79 Convenient process of manufacture for Difluoromethylornithine and related compounds US 7,345,196 Efflornithine
80 Method of preparation and use of coconut water in mamalian tissue nourishment growth and
healthy maintenance
US 7,300,682 Cococin
81 Process for the synthesis of biologically active oxygenated compounds by dealkylation of
the corresponding alkylethers
US 7,253,324 Stilbenes
82 Commercially viable process for high purity of fatty alcohol C24 to C36 and its cosmetic
application for skin hair and nails
US 7,217,546 Policosanol
83 Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus
salts: Process for their manufacture and Uses
US 7,202,270 Liposol®
84 Bioavailable composition of natural and synthetic HCA US 7,063,861 GarCitrin®
85 Compositions and methods containing Allium sativum Linn. (garlic) naturally
enriched with organic selenium compounds for nutritional supplementation
US 7,014,874 SelenoForce®
86 Convenient process of manufacture for Difluoromethylornithine and related compounds US 6,998,502 Efflornithine
87 Compositions and methods containing bioavailable Se-methyl-L-selenocysteine for human and
veterinary use
US 6,982,273 Methyselene® (MSC)
88 Process for preparing water soluble diterpenes and their applications US 6,960,300 Ocufors®
89 Method of increased bioavailability of nutrients and pharmaceutical preparations with
tetrahydropiperine and its analogues and derivatives
US 6,849,645 Cosmoperine® (THP)
90 Manufacturing processes for Se-methyl-selenocysteine US 6,794,537 Methyselene® (MSC)
91 Process of obtaining compositions of stable lutein and lutein derivatives US 6,689,400 ZeaLutein®
92 Composition and methods containing an antimicrobial essential oil extracted from Coleus forskohlii US 6,607,712 Coleus Oil
93 Composition and method containing products extracted from commiphora sp. for prevention and treatment of abnormal cell growth and proliferation in inflammation, neoplasia and cardiovascular disease US 6,436,991 Gugulipid®
94 New Chemical entities with multiple modes of anti-inflammatory action US 7,378,442 AKBBA+NSAIDS
95 New chemical entities with multiple modes of anti-inflammatory action US 7,371,889 AKBBA+NSAIDS
96 Compositions and methods containing natural compounds from nonconventional sources that are useful in maintaining normal blood sugar levels US 7,160,562 Metformin-like compounds
97 Process for the production of potassium hydroxy citric acid, and compositions containing the potassium hydroxy citric acid US 6,770,782 Citrin® K
98 Cross regulin composition of turmeric-derived Tetrahydrocurcuminoids for skin lightening and protection against UVB rays US 6,653,327 Tetrahydrocurcuminoids
99 Process for making high purity piperine for nutritional use US 6,054,585 BioPerine®
100 Use of piperine as a bioavailability enhancer US 5,972,382 BioPerine®
101 Bioprotectant composition, method of use and extraction process of curcuminoids US 5,861,415 Curcumin C3 Complex®
102 Method of preparing a forskolin composition from forskolin extract and use of forskolin for promoting lean body mass and treating mood disorders US 5,804,596 ForsLean®
103 Potassium hydroxycitrate for the suppression of appetite and induction of weight loss US 5,783,603 Citrin® K
104 Use of piperine as a bioavailability enhancer US 5,744,161 BioPerine®
105 Use of piperine to increase bioavailability of nutritional compounds US 5,536,506 BioPerine®
Sl. No. Title Patent No Brand /Ingredient
1 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa Australia
AU2006235807
Curcumin C3 Reduct®
2 Compositions containing thymohydroquinone and their method of preparation Australia
AU2018397667
Nigellin®
3 Alcoholic beverage composition containing Bacillus coagulans Australia
AU2018337853
LactoSpore®
4 Compositions and methods for reducing flatulence Australia
AU2018282018
LactoSpore®
5 Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 Australia
AU2018282252
LactoSporin®
6 Enzyme composition for therapeutic management of muscle soreness Australia
AU2016428484
DigeZyme®
7 Bacillus coagulans MTCC 5856 for the management of major depressive disorder Australia
AU2016413572
LactoSpore®
8 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Australia
AU2015394033
Cyperus
9 Oleanoyl peptide compositions and collagen enhancement Australia
AU2015381703
Olepent®
10 Bioavailable composition of natural and synthetic HCA Australia
AU773081
GarCitrin®
11 Compositions and methods for the management of hyperproliferative dermatological conditions Australia
AU2004322710
Boswellin®
12 Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation Australia
AU2006321973
SelenoForce®
13 Process for preparing water soluble diterpenes and their applications Australia
AU2004272005
Ocufors®
14 Anti-obesity potential of Calebin A Australia
AU2012366253
Calebin
15 Hepatoprotectant activity of garcinol Australia
AU2011352073
Livinol
16 Composition for down-regulating pro-inflammatory markers Australia
AU2011200854
Boswellin® PS
17 Protective compositions for dermal papilla cells Australia
AU2010326651
Saberry® + Cococin
18 Oleanoyl peptide composition and a method of treating skin aging Australia
AU2011265587
Olepent®
19 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Australia
AU2014369819
LactoSporin®
20 Method for the treatment of hypercholesterolemia Australia
AU2014202312
Calebin
21 Synergistic selenopeptide formulations for the protection of dermal papilla cells Australia
AU2012203148
Saberry® + Cococin+ Se Peptide
22 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Australia
AU2015308650
LactoSpore®
23 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Australia
AU2013292593
Cyperus
24 Composition and method for the protection of articular cartilage Australia
AU2014201769
Calebin
25 Anti-obesity potential of Calebin A Australia
AU2014203122
Calebin
26 Process and compositions for achieving mammalian energy balance Australia
AU2015351423
Forskolin
27 Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl) butadiene Australia
AU2016385393
Zingiber cassumnar
28 Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof Australia
AU2018335280
LactoSporin®
29 Synthesis of Calebin A and its biologically active analogs Australia
AU2014203764
Calebin
30 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Australia
AU2017228561
LactoSporin®
31 Use of piperine as a bioavailability enhancer Canada
CA2247467
BioPerine®
32 Forskolin for promoting lean body mass Canada
CA2281562
ForsLean®
33 Novel method for extraction of Oxyresveratrol from Artocarpus hirsutus Canada
CA3047702
Artocarpus hirsutus
34 Composition containing Oroxylin A and method of extraction thereof Canada
CA3043168
Sabroxy®
35 Natural molecules from Artocarpus hirsutus: Method of isolation and anti-acne potential thereof Canada
CA3047701
Artocarpus hirsutus
36 Bacillus coagulans MTCC 5856 For The Management Of Major Depressive Disorder Canada
CA3023818
LactoSpore®
37 Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 Canada
CA2999517
LactoSpore®
38 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Canada
CA2883176
Cyperus
39 Process for preparing water-soluble medicaments comprising complexation of forskolin in cyclodextrins Canada
CA2537820
Ocufors®
40 Anti-obesity Potential of Calebin A Canada
CA2857543
Calebin
41 Composition for down-regulating pro-inflammatory markers Canada
CA2732915
Boswellin® PS
42 Hepatoprotectant activity of garcinol Canada
CA2851663
Livinol
43 Synergistic selenopeptide formulations for the protection of dermal papilla cells Canada
CA2872535
Saberry® + Cococin+ Se Peptide
44 Method for the treatment of hypercholesterolemia Canada
CA2850999
Calebin
45 Synthesis of Calebin A and its biologically active analogs Canada
CA2858126
Calebin
46 Calebin A for hepatic steatosis Canada
CA2893321
Calebin
47 Composition and method for the protection of articular cartilage Canada
CA2935898
Calebin
48 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Canada
CA2899511
LactoSporin®,
LactoSporin® + Sabilize®
49 Method for the treatment of hypercholesterolemia Canada
CA2963383
Calebin
50 Calebin A for osteoporosis Canada
CA2941050
Calebin
51 Oleanoyl peptide composition and collagen enhancement Canada
CA2975170
Olepent®
52 Method to solubilize curcuminoids in water Canada
CA2976689
uC3 CLEAR®
53 Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene Canada
CA2979287
Zingiber cassumnar
54 Method for the treatment of hypercholesterolemia Taiwan
I622384
Calebin
55 Composition for down-regulating pro-inflammatory markers Taiwan
I-434696
Boswellin® PS
56 Method of solubilising forskolin and isoforskolin in water and clear aqueous solution comprising the same Vietnam
12717
Ocufors®
57 Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives Germany
DE10196213
Cosmoperine®
58 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856 Hong kong
HK1240122
LactoSpore®
59 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Hong kong
HK1232483
Cyperus
60 Process and compositions for achieving mammalian energy balance Hong kong
HK1238675
Forskolin
61 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Hong kong
HK1233174
LactoSpore®
62 Synthesis of Calebin A and its biologically active analogs Hong kong
HK1217689
Calebin
63 Process for preparing water soluble diterpenes and their applications Hong kong
HK1098450
Ocufors®
64 Method for the treatment of hypercholesterolemia Hong kong
HK1210590
Calebin
65 Synergistic selenopeptide formulations for the protection of dermal papilla cells Hong kong
HK1193758
Saberry®+ Cococin + Se Peptide
66 Calebin A for articular cartilage Hong kong
HK1210028
Calebin
67 Calebin A for use in the treatment of Inflammation and obesity Hong kong
HK1190874
Calebin
68 Process and compositions for achieving mammalian energy balance China
ZL201580083933.4
Forskolin
69 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 China
ZL201680008035.7
LactoSpore®
70 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof China
ZL201580042813.X
LactoSpore®
71 Process For Preparing Water Soluble Diterpenes And Their Applications China
ZL200480028804.7
Ocufors®
72 Compositions and methods for the management of hyperproliferative dermatological conditions China
ZL200480043675.9
Boswellin®
73 Anti-obesity potential of Calebin A China
ZL201280012577.3
Calebin
74 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof China
ZL201480010615.0
LactoSporin®,
LactoSporin® + Sabilize®
75 Melanogenesis inhibition by 3,5-dimethoxy-4'-hydroxypterostilbenes and cosmeceutical applications thereof DPR Korea
1011504
PteroWhite®
76 Use of piperine as a bioavailability enhancer Europe
EP0810868
BioPerine®
77 Bioprotectant composition, method of use and extraction process of curcuminoids Europe
EP0839037
Curcumin C3 Complex®
78 Forskolin for promoting lean body mass Europe
EP0977564
ForsLean®
79 Neuroprotective compositions and their use Europe
EP3638278
Sabroxy®
80 Enzyme composition for therapeutic management of muscle soreness Europe
EP3534934
DigeZyme®
81 Bacillus coagulans MTCC 5856 for the management of major depressive disorder Europe
EP3478304
LactoSpore®
82 Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 Europe
EP3356545
LactoSpore®
83 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Europe
EP3291805
Cyperus
84 Coconut water and its method of preparation Europe
EP1341547
Cococin
85 Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells Europe
EP1328263
Curcumin C3 Reduct®
86 Bioavailable composition of natural and synthetic HCA Europe
EP1254209
Garcitrin®
87 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 Europe
EP3240553
LactoSpore®
88 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa Europe
EP1171144
Curcumin C3 Reduct®
89 Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation Europe
EP1968620
SelenoForce®
90 Process for preparing water soluble diterpenes and their applications Europe
EP1718568
Ocufors®
91 Compositions and methods for the management of hyperproliferative dermatological conditions Europe
EP1791423
Boswellin®
92 Hepatoprotectant activity of garcinol Europe
EP2658374
Livinol
93 Protective compositions for dermal papilla cells Europe
EP2461786
Saberry® + Cococin
94 Method for the treatment of hypercholesterolemia Europe
EP2937084
Calebin
95 Calebin A for use in the treatment of inflammation and obesity Europe
EP2663185
Calebin
96 Synergistic selenopeptide formulations for the protection of dermal papilla cells Europe
EP2695603
Saberry® + Cococin + Se Peptide
97 Composition and method for the protection of articular cartilage Europe
EP2893926
Calebin
98 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Europe
EP2989197
LactoSporin®
99 Calebin A for inducing lipolysis Europe
EP3085370
Calebin
100 Synthesis of Calebin A and its biologically active analogs Europe
EP2963007
Calebin
101 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Europe
EP2744571
Cyperus
102 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Europe
EP3108935
Cyperus
103 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Europe
EP3185877
LactoSpore®
104 Process and composition for achieving mammalian energy balance Europe
EP3194575
Forskolin
105 Skin care compositions and their applications India
IN356811
Ethyl Asccorbic acid + Sabiwhite®
106 A method for solubilizing forskolin and a composition thereof India
IN235492
Ocufors®
107 A Process of preparing a synergistic composition for treating hyperproliferative dermatological condition India
IN238950
Boswellin®
108 A process for obtaining high purity fatty alcohols India
IN229695
Policosanol
109 Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 Japan
JP7039626
LactoSporin®
110 Compositions for the management of hyperglycemia and related conditions Japan
JP7012857
Nigellin®
111 Compositions and methods for reducing flatulence Japan
JP6987888
LactoSpore®
112 Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof Japan
JP6979518
Oletrip
113 Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 Japan
JP6938479
LactoSpore®
114 Use of Piperine as a bioavailability enhancer Japan
JP3953513
BioPerine®
115 Novel method for extraction of Oxyresveratrol from Artocarpus hirsutus Japan
JP6920462
Artocarpus hirsutus
116 Skin care applications of extracellular metabolites from Bacillus coagulans Japan
JP6918988
LactoSporin®
117 Bacillus coagulans MTCC 5856 for the management of major depressive disorder Japan
JP6908633
LactoSpore®
118 Natural molecules from Artocarpus hirsutus: Method of isolation and anti-acne potential thereof Japan
JP6896885
Artocarpus hirsutus
119 Enzyme composition for therapeutic management of muscle soreness Japan
JP6857240
DigeZyme®
120 Composition containing Oroxylin A and method of extraction thereof Japan
JP6851476
Sabroxy®
121 Composition for management of Helicobacter pylori infection Japan
JP6839329
LactoSpore® + Saberry®
122 Neuroprotective compositions and their use Japan
JP6796217
Sabroxy®
123 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Japan
JP6759243
Cyperus
124 Process of obtaining compositions of stable Lutein and Lutein derivatives Japan
JP4227409
Xenogard®
125 Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives Japan
JP4098985
Cosmoperine®
126 Bio-available compositions of natural and synthetic HCA Japan
JP4205943
GarCitrin®
127 Compositions and methods for the management of hyper-proliferative dermatological conditions Japan
JP4820819
Boswellin®
128 Process for preparing water soluble diterpenes and their applications Japan
JP5021305
Ocufors®
129 Hepatoprotectant activity of garcinol Japan
JP5980228
Livinol
130 Synergistic selenopeptide formulations for the protection of dermal papilla cells Japan
JP6064274
Saberry® + Cococin + Se Peptide
131 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Japan
JP6126307
LactoSporin®,
LactoSporin® + Sabilize®
132 Scirpusin A and Scirpusin B and anti-obesity potential thereof Japan
JP6135761
Cyperus
133 Composition and method for the protection of articular cartilage Japan
JP6142446
Calebin
134 Calebin A for hepatic steatosis Japan
JP6336943
Calebin
135 Oleanoyl peptide composition and a method of treating skin aging Japan
JP6176893
Olepent®
136 Method for the treatment of hypercholesterolemia Japan
JP6263707
Calebin
137 Anti-obesity potential of Calebin A Japan
JP6374716
Calebin
138 Process and compositions for achieving mammalian energy balance Japan
JP6472453
Forskolin
139 Synthesis of Calebin A and its biologically active analogs Japan
JP6490927
Calebin
140 Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene Japan
JP6584526
Zingiber cassumnar
141 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 Japan
JP6629875
LactoSpore®
142 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Japan
JP6630723
LactoSpore®
143 Process and compositions for achieving mammalian energy balance Japan
JP7012857
Nigellin®
144 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 Mexico
MX389328
Forskolin
145 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Mexico
MX376004
LactoSpore®
146 Process for preparing water soluble diterpenes and their applications Mexico
MX260326
Ocufors®
147 Composition for down-regulating pro-inflammatory markers Mexico
MX328842
Boswellin® PS
148 Synergistic selenopeptide formulations for the protection of dermal papilla cells Mexico
MX355546
Saberry® + Cococin +Se Peptide
149 Process and compositions for achieving mammalian energy balance Malaysia
MY-188869-A
Forskolin
150 Oleanoyl peptide composition and collagen enhancement Mexico
MY-188723-A
Olepent®
151 Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 Malaysia
MY-185340-A
LactoSpore®
152 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 Malaysia
MY-182658-A
LactoSpore®
153 Calebin A for hepatic steatosis Malaysia
MY-182000-A
Calebin
154 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Malaysia
MY-181102-A
LactoSporin®
155 Compositions and method for the protection of articular cartilage Malaysia
MY-175867-A
Calebin
156 Synergistic selenopeptide formulations for the protection of dermal papilla cells Malaysia
MY-168089-A
Saberry® + Cococin +Se Peptide
157 Method for the treatment of hypercholesterolemia Malaysia
MY-170067-A
Calebin
158 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Malaysia
MY-174855-A
LactoSpore®
159 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 Newzealand
NZ732234
LactoSpore®
160 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Newzealand
NZ748360
LactoSpore®
161 Bacillus coagulans MTCC 5856 for the management of major depressive disorder Newzealand
NZ748553
LactoSpore®
162 Composition containing Oroxylin A and method of extraction thereof Newzealand
NZ753943
Sabroxy®
163 Enzyme composition for therapeutic management of muscle soreness Newzealand
NZ752952
DigeZyme®
164 Composition for physiological increase of male and female hormones with diterpene forskolin and its derivatives Newzealand
NZ552997
Forskolin
165 Compositions and methods for the management of hyperproliferative dermatological conditions Newzealand
NZ552027
Boswellin®
166 Commercial process for making forskolin and its derivatives Newzealand
NZ568652
Ocufors®
167 Process for preparing water soluble diterpenes and their applications Newzealand
NZ545765
Ocufors®
168 Bioavailable composition of natural and synthetic HCA Newzealand
NZ518116
GarCitrin®
169 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa Newzealand
NZ514884
Curcumin C3 Reduct®
170 Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation Newzealand
NZ568233
SelenoForce®
171 Protective compositions for dermal papilla cells Newzealand
NZ598630
Saberry®+ Cococin
172 Synergistic selenopeptide formulations for the protection of dermal papilla cells Newzealand
NZ600307
Saberry®+ Cococin + Se dipeptide
173 Method for the treatment of hypercholesterolemia Newzealand
NZ624269
Calebin
174 Hepatoprotectant activity of garcinol Newzealand
NZ609878
Livinol
175 Anti-obesity potential of Calebin A Newzealand
NZ614076
Calebin
176 Synthesis of Calebin A and its biologically active analogs Newzealand
NZ627247
Calebin
177 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Newzealand
NZ622927
Cyperus
178 Anti-obesity potential of calebin A Newzealand
NZ715053
Calebin
179 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Newzealand
NZ711345
LactoSporin®,
LactoSporin® + Sabilize®
180 Composition and method for the protection of articular cartilage Newzealand
NZ622909
Calebin
181 Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene Newzealand
NZ735027
Zingiber cassumnar
182 Method to solubilize curcuminoids in water Newzealand
NZ734491
UC3 clear®
183 Process and compositions for achieving mammalian energy balance Newzealand
NZ720422
Forskolin
184 Anti-pollution compositions containing Bacillus coagulans Russia
RU2745755
LactoSpore®
185 Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof Russia
RU2733372
Oletrip
186 Compositions and methods for the management of hyperproliferative dermatological conditions Russia
RU2366412
Boswellin®
187 Anti-obesity potential of Calebin A Russia
RU2543334
Calebin
188 Hepatoprotectant activity of garcinol Russia
RU2585245
Livinol
189 Synergistic selenopeptide formulations for the protection of dermal papilla cells Russia
RU2606752
Saberry® + Cococin + Se Peptide
190 Calebin A for hepatic steatosis Russia
RU2643297
Calebin
191 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Russia
RU2617965
LactoSporin®,
LactoSporin® + Sabilize®
192 Calebin A for osteoporosis Russia
RU2653103
Calebin
193 Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene Russia
RU2694053
Zingiber cassumnar
194 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Russia
RU2691404
Cyperus
195 Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene Singapore
SG11201707112P
Zingiber cassumnar
196 Process and compositions for achieving mammalian energy balance Singapore
SG11201801873T
Forskolin
197 Process for preparing water soluble diterpenes and their applications Singapore
SG121197
Ocufors®
198 Compositions and methods for the management of hyperproliferative dermatological conditions Singapore
SG136165
Boswellin®
199 Calebin A for hepatic steatosis Singapore
SG10201503805X
Calebin
200 Composition and methods for the protection of articular cartilage Singapore
SG11201605336Y
Calebin
201 Anti-obesity potential of calebin A Singapore
SG192695
Calebin
202 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Singapore
SG11201505628P
LactoSporin®,
LactoSporin® + Sabilize®
203 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Singapore
SG11201700006U
LactoSpore®
204 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Singapore
SG11201707106U
Cyperus
205 Liver protectant composition and therapeutic applications South Africa
ZA2020/06540
LivLonga®
206 Modulation of immune function by Bacillus coagulans South Africa
ZA2020/07348
Immunospore
207 Skin care compositions and their applications South Africa
ZA2020/06708
Ethyl Ascorbic Acid + SabiWhite®
208 Compositions for the management of hyperglycemia and related conditions South Africa
ZA2020/04532
Nigellin®
209 Bacillus coagulans MTCC 5856 for the management of major depressive disorder South Africa
ZA2019/00501
LactoSpore®
210 Enzyme composition for maintenance of metabolic health South Africa
2019/07676
DigeZyme®
211 Composition and methods for the management of hyperproliferative dermatological Conditions South Africa
ZA2007/0694
Boswellin®
212 Process for preparing water soluble diterpenes and their applications South Africa
ZA2006/01898
Ocufors®
213 Anti-obesity potential of Calebin A South Africa
ZA2013/05918
Calebin
214 Method to solubilize curcuminoids in water South Africa
ZA2017/06503
UC3 Clear®
215 Enzyme composition for therapeutic management of muscle soreness South Africa
ZA2019/02715
DigeZyme®
216 Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives Great Britain
GB2380675
Cosmoperine®
217 Process for preparing water soluble diterpenes and their application Uzbekistan
4028
Ocufors®
218 Process and composition for achieving mammalian energy balance Eurasia
EA38685
Forskolin
219 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856 Eurasia
EA037312
LactoSpore®
220 Process for preparing water soluble diterpenes and their applications Eurasia
EA012836
Ocufors®
221 Bacillus coagulans MTCC 5856 for the management of major depressive disorder Eurasia
EA038255
LactoSpore®
222 Protective compositions for dermal papilla cells Eurasia
EA20368
Saberry® + Cococin
223 Use of a composition for down-regulating/inhibiting PGE2 Eurasia
EA023717
Boswellin® PS
224 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Eurasia
EA025578
Cyperus
225 Method for the treatment of hypercholesterolemia Eurasia
EA027148
Calebin
226 Use of calebin A to protect mammalian articular cartilage from pathological damage Eurasia
EA027614
Calebin
227 Synthesis of calebin A and its biologically active analogs Eurasia
EA027726
Calebin
228 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Eurasia
EA034017
LactoSpore®
229 Oleanoyl peptide composition and collagen enhancement Eurasia
EA03512
Olepent®
230 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 Philippines
PH1-2017-50132
LactoSpore®
231 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Philippines
PH1-2017-500059
LactoSpore®
232 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Philippines
PH1-2015-500349
Cyperus
233 Process for preparing water soluble diterpenes and their applications Philippines
PH1-2006-500481
Ocufors®
234 Method for the treatment of hypercholesterolemia Philippines
PH1-2014-000244
Calebin
235 Calebin A for hepatic steatosis Philippines
PH1-2015-000188
Calebin
236 Composition and method for the protection of articular cartilage Philippines
PH1-2016-501138
Calebin
237 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Philippines
PH1-2015-502025
LactoSporin®,
LactoSporin® + Sabilize®
238 Anti-pollution compositions containing Bacillus coagulans Republic of Korea
KR10-2376076
LactoSpore®
239 Skin care applications of extracellular metabolites from Bacillus coagulans Republic of Korea
KR10-2296051
LactoSporin®
240 Anti-obesity potential of garcinol Republic of Korea
KR10-2289324
Garcinol
241 Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 Republic of Korea
KR10-2288904
LactoSporin®
242 Hair care compositions containing extracellular metabolite preparation from Bacillus coagulans Republic of Korea
KR10-2288897
LactoSporin®
243 Process and compositions for achieving mammalian energy balance Republic of Korea
KR10-2169620
Forskolin
244 Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856 Republic of Korea
KR10-2157043
LactoSpore®
245 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Republic of Korea
KR10-1600212
Cyperus
246 Synthesis of Calebin A and its biologically active analogs Republic of Korea
KR10-1629561
Calebin
247 Method for the treatment of hypercholesterolemia Republic of Korea
KR10-1647549
Calebin
248 Composition and method for the protection of articular cartilage Republic of Korea
KR10-1685263
Calebin
249 Composition and method for the protection of articular cartilage Republic of Korea
KR10-1685333
Calebin
240 Anti-obesity potential of Calebin A Republic of Korea
KR10-1702702
Calebin
251 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Republic of Korea
KR10-1717889
Cyperus
252 Calebin A for hepatic steatosis Republic of Korea
KR10-1763474
Calebin
253 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Republic of Korea
KR 10-1770902
LactoSporin®,
LactoSporin® + Sabilize®
254 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Republic of Korea
KR10-2089566
LactoSpore®
255 Oleanoyl peptide composition and collagen enhancement Indonesia
IDP000074771
Olepent®
256 Novel pcr primers and methods thereof for the identification of Bacillus coagulans Indonesia
IDP000074645
LactoSpore®
257 Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Indonesia
PID201708495
Cyperus
258 Process and compositions for achieving mammalian energy balance Indonesia
IDP000071226
ForsLean®
259 Calebin A for hepatic steatosis Indonesia
IDP000067993
Calebin
260 Synergistic selenopeptide formulations for the protection of dermal papilla cell Indonesia
IDP000051688
Saberry® + Cococin + Se-dipeptide
261 Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Indonesia
IDP00201506134
LactoSporin®,
LactoSporin® + Sabilize®
262 Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof Indonesia
IDP000062703
Cyperus
263 Calebin A and its effect on hypercholesterolemia Indonesia
IDP000064827
Calebin
264 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Indonesia
IDP000066793
LactoSpore®
265 Compositions and methods for the management of hyperproliferative dermatological conditions United Arab Emirates
AE3178
Boswellin®
  • Active
  • Expired